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Artificial blood, other innovations
could save lives
Transforming 
      trauma care
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 7  Building connections
    A new campus plan brings communities together and improves 
experiences for employees, patients, students and visitors.  
10  Gateway to care 
    Infectious disease doctor Rupa Patel is raising worldwide aware-
ness about a single daily pill that is effective at preventing HIV. 
16  Battlefield to bedside 
    Together, blood transfusion specialists, surgeons and the military are 
advancing care for wounded soldiers and civilian trauma patients.
24  Match Day 2017 
   Graduating students learn where they will spend their residency.
COVER   ErythroMer, a red blood cell 
substitute formulated from freeze-dried 
hemoglobin (shown above), which has 
shown success in small animal trials, may 
become available for human use within 10 
years. On the battlefield and in desolate  
locations, such a preparation could be 
mixed with water at the point of care to 
treat traumatic bleeding. See page 16. 
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Rupa Patel, MD, MPH, speaks with  
Keith Cotton, owner of Boardwalk 
Waffles & Ice Cream in St. Louis, about 
PrEP, a single daily pill that helps prevent 
HIV. As part of her community outreach 
efforts, Patel distributes informational 
posters on PrEP to local businesses.  
See page 10.
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Jennifer Duong, left, and 
Rosie Tang show off their 
Match Day letters. Duong is 
headed to Seattle Children’s 
Hospital for pediatrics; Tang is 
going to Duke University for 
anesthesiology. See page 24.
As her premature baby struggled for survival in 
the neonatal intensive care unit, Robin Torrence-
Webber, right, became anxious and depressed. 
She credits therapist Anna Constantino-Pettit, 
MSW ’14, left, with lifting her spirits and teaching  
her to cope. See page 26.
DEPAR TMENTS
 2  Pulse 
 
26    Alumni &  
Development  
  26  Caring for mom  
& baby
  29 Needed: 500 alumni
  30 Classnotes 
Washington University School of Medicine   
O U T L O O K . W U S T L . E D U    S P R I N G  2 0 1 7
RO
BE
RT
 B
OS
TO
N
RO
BE
RT
 B
OS
TO
N
RO
BE
RT
 B
OS
TO
N
171523_IFC-TOC_TOCv6_cc17.indd   2 5/2/17   12:47 PM
RO
BE
RT
 B
OS
TO
N
GE
TT
Y 
IM
AG
ES
elders exposed to airborne 
manganese at estimated 
levels below federal 
occupational safety standards exhibit 
neurological problems similar to 
Parkinson’s disease, according to  
new research. 
The findings, published Dec. 28  
in Neurology, suggest that current  
safety standards may not adequately 
protect welders.
“We found that chronic exposure to 
manganese-containing welding fumes is 
associated with progressive neurological 
symptoms,” said Brad A. Racette, MD, a 
professor of neurology and the study’s 
senior author. “The more exposure you 
have to welding fumes, the more quickly 
those symptoms progress over time.”
At high levels, manganese — a key 
component of important industrial 
processes such as welding and steelmaking 
— can cause manganism, a severe 
neurologic disorder with symptoms similar 
to Parkinson’s disease, including slowness, 
clumsiness, tremors, mood changes and 
difficulty walking and speaking. 
Decades ago, this risk drove the 
Occupational Safety and Health 
Administration (OSHA) to set standards 
limiting the amount of manganese in the 
air at workplaces. These safety standards 
are widely believed to have eliminated 
manganism as an occupational hazard. 
Researchers, however, have long 
suspected that there may still be some 
health effects at levels much lower than 
what is allowable per OSHA standards.
This is the first study showing clinically 
relevant health effects occurring at estimated 
exposures lower than the OSHA limit.
Racette and colleagues studied 886 
welders at three worksites in the Midwest 
— two shipyards and one heavy-
machinery fabrication shop. Each welder 
filled out a detailed job history 
questionnaire and underwent at least two 
standardized clinical evaluations of motor 
function spaced a year or more apart.
The most worrisome aspect of the 
study, Racette said, is that the 
neurological signs showed up in people 
with an estimated exposure of only 0.14 
milligrams of manganese per cubic meter 
of air, far below the safety standard set by 
OSHA at 5 milligrams per cubic meter.
pulse
Study findings suggest that 
current allowable limits for 
manganese exposure are not 
adequately protecting welders.
Danger in the workplace
W
Manganese-containing welding fumes linked to neurological problems
Spring 20172  Washington University School of Medicine
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U.S. hospitals can improve patient care and reduce costs if 
cardiologists perform more coronary angioplasties through 
wrist arteries, and if they take steps to discharge patients on 
the same day, according to a new study. 
Coronary angioplasty, also called percutaneous coronary 
intervention (PCI), is performed to alleviate chest pain or 
shortness of breath. Interventional cardiologists increase 
blood ow to the heart by inserting a small tube via an artery 
in the groin or wrist, opening up the narrowed section with 
an inatable balloon, and possibly placing a stent.
Shiing standard practice by 30 percent — from the groin 
to the wrist approach — along with same-day discharge, 
could save the U.S. 
$300 million per year, 
researchers estimate.
 “e traditional way 
has been to go through 
the bigger femoral 
artery that is a straight 
pathway to the heart,” 
said rst author Amit P. 
Amin, MD, an assistant 
professor of medicine. 
“Unfortunately, that 
artery is also deep. It’s 
associated with more bleeding complications. When we go 
in through a vessel in the wrist, we see less bleeding, fewer 
complications, less pain and discomfort, higher patient 
satisfaction, shorter hospital stays and lower costs.” 
Improved technology has allowed wrist access to  
become a viable route, even for complex cases, Amin said. 
e researchers analyzed data from almost 280,000 
Medicare patients who underwent PCI and were eligible for 
same-day discharge. Only about 5 percent of these patients 
actually were discharged prior to staying overnight.
“We have seen that it is very safe to send these patients 
home the same day,” Amin said. “We use risk-prediction 
models to predict their risks ahead of time, and we plan 
ahead to mitigate any issues so we can facilitate a same-day 
discharge. We want to outline health-care pathways that 
provide the best care for patients.”
For the groin approach with at least one night of 
hospitalization, the average cost is $17,076. e average cost 
for the wrist approach with same-day discharge is $13,389. 
Independent of the length of stay, the wrist approach costs 
about $900 less than the groin approach.
Health-care costs for the 600,000 patients who receive  
PCI annually in the U.S. are estimated at $10 billion.
Heart procedure changes 
could improve outcomes
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Danger in the workplace
Yawning and scratching are socially contagious behaviors; if 
one person does it, others are likely to follow suit. School of 
Medicine researchers now have found that socially contagious 
itching is hardwired in the brain. e discovery, published 
in Science, may help scientists understand the neural circuits 
that control socially contagious behaviors. 
Researchers put a mouse in 
an enclosure with a computer 
screen, and then played a 
video showing another mouse 
scratching. Within seconds, the 
mouse in the enclosure started 
scratching, too.
Next, the researchers zeroed 
in on a brain region called the 
suprachiasmatic nucleus, which 
regulates sleep/wake cycles. 
When the mouse saw other mice 
scratching, this nucleus released a chemical substance  
called GRP (gastrin-releasing peptide). 
“e mouse doesn’t see another mouse scratching and 
then think it might need to scratch, too,” said principal 
investigator Zhou-Feng Chen, PhD, director of the Center  
for the Study of Itch. “Instead, its brain begins sending out 
itch signals using GRP as a messenger.”
When Chen’s team used various methods to block the 
chemical or receptors, the mice did not scratch when they 
saw others scratch. 
“Many people thought it was all in the mind, but our 
experiments show it is a hardwired behavior and is not a  
form of empathy,” Chen said.
Brain hardwired to respond to itching
MUCHLOVED EDUCATORS  Glenn C. Conroy, 
PhD,  and Jane Phillips-Conroy, PhD, celebrated retirement 
this April. The Conroys have taught anatomy to every single 
medical student for the past 32 years, since joining the faculty 
in 1983. They are revered by medical students not only as 
accomplished anthropologists, but for their skill and dedica-
tion in teaching the Human Anatomy and Development 
course, a cornerstone of the medical school experience. 
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Women who pursue in vitro fertilization (IVF) are more 
likely to give birth if they have health insurance that covers 
the procedure, according to new research.
e key reason is nancial: e high cost prohibits most 
women from seeking a second treatment if the rst attempt fails.
e study is published in e Journal of the American 
Medical Association.
“It’s a simple and 
possibly obvious 
nding, but it high-
lights the importance 
of health insurance 
in the outcome of 
fertility treatments,” 
said lead author 
Emily S. Jungheim, 
MD, an associate 
professor of obstetrics  
and gynecology. 
“e biggest hurdle 
may not be the fertility treatment but the cost.”
e American Pregnancy Association estimates the cost 
of a single IVF treatment at $12,000 to $17,000. e success 
of one IVF procedure ranges from more than 40 percent for 
women under age 35 to about 15 percent for women over age 
40. Other factors inuencing success include lifestyle, cause 
of infertility and reproductive history.
e study examined data from 1,572 women seeking  
IVF treatment from 2001 to 2010 at Washington University’s 
Fertility and Reproductive Medicine Center. e clinic 
serves women in Missouri and Illinois. e location is  
signicant to study ndings as Illinois mandates IVF  
coverage, while Missouri does not.
Seventy percent of women with insurance returned for a 
second IVF treatment if the rst treatment was unsuccessful.
For women with coverage, the average likelihood of  
giving birth aer up to four attempts was 59 percent, or  
515 births. is compared with 51 percent, or 350 births,  
for women without such coverage — a dierence that is  
statistically signicant.
Fieen states have infertility insurance laws; however, only 
ve have comprehensive mandates that include IVF: Illinois, 
Massachusetts, Rhode Island, Connecticut and New Jersey.
Researchers from Washington University’s Olin Business 
School and the Brown School contributed to the study. 
Insurance influences 
pregnancy success
Emily S. Jungheim, MD, examines oocytes retrieved 
during an in vitro fertilization procedure. 
RO
BE
RT
 B
OS
TO
N
Paul J. Scheel Jr., MD, a physician-
leader at Johns Hopkins University 
School of Medicine, has been  
named associate vice chancellor 
for clinical aairs at Washington 
University School of Medicine and 
chief executive ocer of Washington 
University Physicians, the school’s  
faculty practice group. His appoint-
ment begins July 1.
Washington University Physicians ranks among the  
largest academic group practices in the U.S. 
Scheel serves as vice president of the Oce of Johns 
Hopkins Physicians in the Johns Hopkins Health System  
and medical director of Integrated Renal Solutions of  
Johns Hopkins Healthcare in Baltimore. He also is the 
Ronald Peterson Professor of Medicine and director of  
the Division of Nephrology at Johns Hopkins University 
School of Medicine.
Scheel succeeds James P. Crane, MD, associate vice  
chancellor for clinical aairs, who led Washington 
University Physicians for 25 years. In that time, the  
clinical practice has grown substantially and draws  
patients from across the country.
Paul Scheel’s wife, Janet Scheel, MD, will join the 
Department of Pediatrics as associate medical director  
of the heart failure and transplant program in the  
Division of Cardiology.
e Scheels have two children: Paul recently graduated 
from Washington University School of Medicine and is an 
intern at Johns Hopkins; Amy works in public health and 
conducts research in Uganda.
Scheel to head faculty practice plan
Paul J. Scheel Jr., MD
DISTINGUISHED CONTRIBUTIONS  Three 
professors have been selected as fellows of the American 
Association for the Advancement of Science, the world’s 
largest general scientific society. From left, the fellows are: 
Azad Bonni, MD, PhD, the Edison Professor of Neurobiology 
and head of the Department of Neuroscience; Phyllis I. 
Hanson, MD, PhD, the Gerty T. Cori Professor at the School  
of Medicine; and Gary D. Stormo, PhD, the Joseph Erlanger 
Professor in the Department of Genetics.
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 combination of two topical 
drugs that have been in use for 
years triggers a robust immune 
response against precancerous skin lesions, 
according to researchers from Washington 
University and Harvard medical schools. 
The study, involving 132 patients with 
actinic keratosis, a precursor to squamous  
cell carcinoma, is published in The Journal  
of Clinical Investigation.
“We looked at precancerous lesions 
on patients with sun-damaged skin,” said 
study co-author Lynn A. Cornelius, MD, the 
Winfred A. and Emma R. Showman Professor 
of Dermatology and director of the Division 
of Dermatology. “Most commonly found on 
the face, scalp and arms, these lesions appear 
abnormal by visual examination and under the 
microscope but are not full-blown skin cancers.”
These lesions have the potential to 
develop into a true skin cancer and are 
commonly treated.
On average, the investigational therapy 
reduced the number of precancerous skin 
lesions on the face by almost 88 percent 
compared with a 26 percent reduction using 
the standard chemotherapy. 
While side effects such as skin scaling and 
itching were similar with both treatments, 
Topical drugs eective against early skin cancer
A patients receiving the investigational therapy reported more redness 
and increased burning 
sensations, which  
are consistent with  
the immune response  
it triggers. 
Interestingly, although 
not specifically measured, 
patients who had been 
treated previously with 
conventional therapies 
reported decreased pain 
and discomfort with the 
combination treatment, Cornelius said.
The investigational treatment combines 
5-fluorouracil, a cream formulation of a 
chemotherapy drug prescribed to treat actinic 
keratosis, with a synthetic form of vitamin 
D called calcipotriol. The FDA has approved 
calcipotriol for treatment of psoriasis, an 
autoimmune disorder characterized by red, 
scaly patches of skin.
Prior studies in mice prone to allergic 
inflammation, especially eczema on the skin, 
suggest that overreactive immunity triggered 
by damaged skin may have a significant 
benefit — a hyper-vigilant system that  
attacks cancerous cells. 
Earlier work at Washington University by 
senior author Shadmehr Demehri, MD, PhD, 
now at Harvard, showed that a protein in 
the skin called TSLP activates the immune 
system’s T cells. Calcipotriol also is known to 
cause the skin to produce TSLP. 
The therapy induces a heightened 
immune response in the skin, and the 
chemotherapy drug works to destroy the 
cancerous cells. 
#ILookLikeASurgeon
A magazine cover from The New Yorker 
inspired women surgeons worldwide 
to post pictures of themselves on social 
media and, of course, Washington 
University had to take part. Left, 
female surgeons from the School of 
Medicine re-create the cover pose. 
French artist Malika Favre created 
the April 3 cover illustration for The 
New Yorker from the perspective of a 
patient, with four female surgeons peering down. The illustration soon 
went viral, as women surgeons took work selfies and posted them on 
Twitter, Facebook and Instagram. In covering the trend, CBS News high-
lighted the Washington University photo.
Dermatologist Lynn A. Cornelius, MD, left, conducts 
a skin exam with patient Robert Manchester. 
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School of Medicine researchers are key collaborators in 
a multicenter study that has found associations between 
brain connectivity and a social behavior that is a key  
feature of autism. 
Conducted through the Infant Brain Imaging Study 
network, the collaboration also included scientists from the 
University of North Carolina, e Children’s Hospital of 
Philadelphia and the University of Washington.
Using functional MRI, researchers sought to identify 
brain networks involved in “initiation of joint attention.” 
is is what it’s called when a baby sees an object, such as  
a dog or a ball, focuses 
on that object and — 
by pointing and/or 
shiing gaze — gets 
someone else to focus 
on that object, too. 
It’s a behavior that is 
impaired in children 
with autism spectrum 
disorder.
“By the time most 
children are diagnosed 
with autism, they are  
4 ½, but in studying  
the brains of younger 
children, we have found neural activity that may allow for  
earlier diagnosis, and that, in turn, may allow us to begin 
treatment sooner,” said John R. Pruett Jr., MD, PhD, co-
senior author and an associate professor of child psychiatry. 
e researchers scanned the brains of more than  
200 sleeping toddlers. e next day, researchers watched  
to see how oen the children initiated joint attention.
ose less likely to initiate joint attention had strong 
connections between their brains’ visual and dorsal  
attention networks. e dorsal attention network keeps 
focused attention on something while still allowing the 
brain to respond to other sensory information.
ose more likely to initiate joint attention had stronger 
functional connectivity between the visual and the default 
mode networks. e default mode network is most active 
during quiet rest or daydreaming but generally shuts down 
while one is focused on a challenging task.
First author Adam T. Eggebrecht, PhD, an instructor in 
radiology, said the visual and default mode regions tend to 
work together, while the visual and attention regions tend 
to decouple: “In these scans we’re seeing something like a 
ngerprint of how brain networks coordinate activity.” 
Insights into autism
Brain networks may underlie social behavior
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NATIONAL LEADERSHIP Timothy J. Eberlein, MD, 
head of the Department of Surgery, testifies before a U.S. 
Senate subcommittee March 8 regarding federal funding  
for medical research. Such funding is critical in developing 
innovative therapies and vital to the careers of young scientists 
whose ideas and work help improve patient outcomes, he 
said. The subcommittee makes recommendations on National 
Institutes of Health (NIH) funding. Sen. Roy Blunt, R-Mo., the 
subcommittee chairman, invited Eberlein to testify.
Aspiration therapy oers signicantly overweight people a 
means to rid their bodies of excess calories before digestion.
e FDA-approved, nonsurgical therapy was developed 
by School of Medicine researchers, who have been following 
study patients for three years. “It’s been very successful, 
with study patients losing an average of 14 percent of their 
total body weight, almost double the amount seen with  
other nonsurgical 
procedures and similar 
to weight loss seen 
with some surgical 
procedures,” said 
Vladimir Kushnir, MD, 
an assistant professor  
of medicine and 
director of the Bariatric 
Endoscopy Program.
Kushnir uses an 
endscope to place a 
small, discreet device 
into the stomach, a tube 
that is undetectable beneath a shirt or a one-piece bathing 
suit. at tube, similar to a port used to get drugs into the 
body, protrudes slightly from the skin.
For the device to work, a patient goes to a restroom  
30 to 60 minutes aer eating, connects the tube to an 
external apparatus and removes about one-third of the  
food eaten. Most patients perform aspiration therapy once 
or twice each day, aer the largest meals they consume.
Weight-loss therapy rids body of food
Vladimir Kushnir, MD, and research  
coordinator and dietitian Abigail Lowe.
Brain networks may play a role when a child sees 
an object and gets someone else to focus on the 
object, too. 
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A new campus plan brings communities together and improves 
the experience for employees, patients, students and visitors.
B Y  G A I A  R E M E R O W S K I
Building connections
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       C L I N I C A L  C A R E 
The medical school’s clinical 
practice has tripled in size 
over the past 15 years. Visits 
to the Center for Advanced 
Medicine are expected to 
continue to grow to 500,000 
by 2020. Five floors of the 
Center for Outpatient Health 
administrative offices have been 
moved to the Mid Campus Center  
to make way for this increasing 
patient volume. This has allowed for 
multiple clinical programs to expand, 
including additional oncology infusion  
bays. The medical school also is working  
with hospital partners to improve signage,  
valet service, pathways and operations with  
the goal of enhancing the patient and  
visitor experience.
    CO L L A B O R AT I O N 
Many operational and administrative 
services of the medical school and BJC 
HealthCare now are housed together in 
the new Mid Campus Center, located 
in the heart of campus. The 12-story 
building includes a joint emergency 
command center and enhanced 
meeting rooms and consolidates 
the school’s administrative offices, 
including the Dean’s office, Human 
Resources, General Counsel, Finance, 
Medical Public Affairs and others. This 
single administrative location aims 
to encourage efficiency and eliminate 
technological redundancies, while 
allowing for serendipitous collisions 
and collaborations. New faculty offices 
free up space in clinical care buildings, 
allowing for expanded patient services. 
Integrating safety operations also provides 
an additional level of campus security.
              ver the past few years,
              Washington University  
Medical Center has been abuzz with 
construction, renovation and relocation 
of many departments. Behind this 
seemingly chaotic scene is a highly 
structured physical campus plan  
aimed at better integrating education 
and work spaces, student housing, 
pedestrian paths, and retail and social 
oerings. e hope behind such eorts 
is to forge new connections and improve 
the overall experience for those who 
frequent this bustling urban campus. 
“Our goal is to bring people together 
in ways they haven’t connected before 
and to make our campus more inviting 
for visitors, patients, students and 
employees,” said Melissa Hopkins,  
the school’s assistant vice chancellor  
and assistant dean of operations and 
facilities management.
Working with hospital partners and 
the neighboring Cortex Innovation 
Community, planners have undertaken 
a comprehensive review — looking 
at everything from changing health-
care needs and daily trac patterns to 
operational eciency and sustainability.
e key objectives: enhance 
education, drive talent, improve access 
and safety, expand clinical care and 
achieve better health outcomes.
 CO L L A B O R AT I O N  
 A M E N I T I E S
 S T U D E N T  L I F E 
 PAT H WAYS
 C L I N I C A L  C A R E
Serendipity 
as strategy
8  Washington University School of Medicine
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         A M E N I T I E S 
Amenities include: a Kaldi’s Cafe in the Mid Campus 
Center, Farmstead cafe serving locally sourced 
food in the McDonnell Pediatric Research Building, 
and an improved, dedicated space for food trucks, 
complete with green space and picnic benches. A new 
bookstore in the Mid Campus Center includes a FedEx 
kiosk. A larger FedEx facility will open in the Clinical 
Sciences Research Building link. Expanded and improved 
lactation rooms aim to reduce barriers to breastfeeding 
for all new mothers on campus.
      PAT H WAYS 
Plans to improve campus access and safety 
include enhancing the Central West End 
MetroLink arrival experience with an  
extended platform and better pedestrian 
circulation routes and adding a new station 
east of Boyle Avenue. Already completed:  
an elevated walkway link, which now connects 
four employee garages to the hospitals and west 
part of campus, a new 3,000-space Duncan 
Central Garage, defined bike and pedestrian 
pathways, additional and clearer signage, and 
new traffic signals and turn lanes to make 
intersection crossings easier.
       S T U D E N T  L I F E 
To enhance the student experience and 
revitalize historic sites, apartment-style 
housing is being built in the original 
Central Institute for the Deaf and the 
original Shriner’s Hospital. The facilities 
will house 197 beds, additional common 
space for expanded fitness and recreation 
opportunities, a music room and 
community center. In this increasingly 
digital age, Bernard Becker Library has 
removed three floors of stacks to create a 
centralized interactive educational hub with 
space for education offices and all their affiliated 
services. The library also will house the Feuerstein 
Health and Wellness Information Center that will 
bring together services and resources for students, 
faculty and staff. 
171523_7-9_CCv8_cc17.indd  9 5/2/17  12:21 PM
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In 1978, during the infancy of the AIDS epidemic, reports 
about isolated cases of gay men suering from a rare lung 
infection and an aggressive cancer began trickling in to 
the Centers for Disease Control and Prevention (CDC).
at same year, Rupa Patel was born in the Midwest 
to immigrants from rural Indian villages. While her 
parents worked long hours in medicine and business, 
Patel became family mama-bear, a persistent protector 
helping her non-English speaking, illiterate grandmother 
as well as her little brother — who never quite t in — 
navigate life in white suburban Michigan.
By the time Patel earned a medical degree in 2004, 
her brother had acknowledged he was gay, and she 
had discovered a passion for treating people who were 
emotionally vulnerable, socioeconomically disadvantaged 
and at risk for contracting human immunodeciency 
virus (HIV), the virus that causes AIDS.
For Patel, MD, MPH, Washington University 
School of Medicine — with its international reputation 
for developing HIV/AIDS prevention and treatment 
therapies — beckoned. She arrived on campus in  
2013 as an instructor of medicine in the Division of 
Infectious Diseases.
Gateway  
to care
Outlook  11
Fighting social stigma and barriers, doctor seeks  
to prevent HIV infections worldwide. 
B Y  K R I S T I N A  S A U E R W E I N
In Africa, Assistant Professor Rupa
Patel, MD, MPH, meets with team
members from Jhpiego. This non-
profit organization works with Kenyan 
governmental leaders to implement 
HIV prevention throughout the country.
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I knew this would be an excellent place forme to make an impact on the communityas well as in the medical eld,” said Patel,
who favors her division’s emphasis on
hands-on research and community outreach.
“Also, importantly, the HIV/AIDS scientists here
are world-renowned.”
eir inuential body of work ranges from 
research on the potent multidrug AIDS “cocktails” 
developed in the 1980s to ongoing analysis of the 
relationship between the virus and inammation 
to recent studies on the role of gut microbial 
communities in HIV/AIDS. Such eorts have 
helped to commute AIDS from a death sentence 
that, thus far, has claimed 35 million lives globally 
to a chronic and manageable disease, with 
treatments that provide a normal life expectancy.
Patel’s mission is to prevent HIV infections 
altogether. From urban St. Louis to the rural 
Midwest to remote African and Asian villages, 
Patel advocates for a once-daily pill called PrEP, 
which stands for “pre-exposure prophylaxis.” 
Studies have shown that pre-emptive use of this 
antiviral drug, when taken consistently, decreases 
the risk of HIV infection more than 90 percent. In 
illicit drug users who share needles, PrEP is more 
than 70 percent eective at reducing risk.
PrEP contains Truvada, which the U.S. Food 
and Drug Administration approved in 2012 as  
“an important milestone in our ght against  
HIV.” e CDC and World Health Organization 
(WHO) also endorse PrEP.
“PrEP is a game changer for HIV prevention,” 
said Patel, director of the PrEP Program at the 
Washington University Infectious Diseases Clinic 
and a PrEP advisory group member for the WHO.
In her various roles, Patel has helped revise 
international PrEP guidelines and consulted for 
PrEP programs in places such as Brazil, South 
Africa and, most recently, India and Kenya. HIV 
rates in these countries are especially high among 
teens and young women who work in the sex 
industry. “PrEP’s public health implications are 
profound,” Patel said.
e CDC estimates that 1.2 million Americans 
live with HIV; of those, approximately two-thirds 
are not in treatment. Yearly, 40,000 people in the 
U.S. receive an HIV diagnosis, but those numbers 
have declined about 19 percent since 2005.
However, HIV rates are climbing among 
certain populations — in men who have sex 
with men and in African-Americans and other 
minorities. Reasons include a lack of health-care 
access, cultural and social stigmas and an overall 
distrust of the medical profession, a particular 
problem in the African-American community.
“It is critical to knock down these barriers,” 
said Patel, noting that the HIV-infected who are 
untreated or undiagnosed are the most likely to 
transmit the virus.
Other preventive treatments also are advancing. 
Patel, along with Rachel Presti, MD, PhD, the HIV 
director of the school’s AIDS Clinical Trials Unit, 
and other investigators, are leading a clinical trial 
testing an injectable drug that prevents HIV and 
only needs to be given every two months.
“Although AIDS is no longer a death sentence, 
HIV prevention remains a public health priority,” 
said William G. Powderly, MD, co-director of the 
infectious diseases division and one of the reasons 
Patel wanted to work at the medical school.  
“HIV/AIDS is not a situation that is going away 
any time soon. In a short period, Rupa Patel 
has done a remarkable job establishing PrEP 
in St. Louis and globally while also conducting 
inuential research,” added Powderly, who also 
Rupa Patel, a PrEP advisory group 
member for the World Health 
Organization, travels around the 
globe raising awareness about HIV 
prevention.
12  Washington University School of Medicine
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is the J. William Campbell Professor of Medicine 
and the Larry J. Shapiro Director of the Institute 
for Public Health. “She has become a leading 
expert on PrEP.”
Serving at home and abroad
Truvada combines two medications — emtricitabine 
and tenofovir disoproxil fumarate, both used in 
HIV treatment regimes. For people exposed to 
HIV, Truvada inhibits virus replication while typi-
cally causing minimal side eects.
“It’s a primary prevention strategy like taking 
aspirin daily to prevent a heart attack,” Patel said.
Since 2014, Patel has led PrEP clinical trials in 
St. Louis with a focus on raising awareness among 
primary care physicians and high-risk individuals. 
e drug — which costs approximately  
$1,500 for a 30-day supply — is covered through 
health insurance or nancial assistance from  
the manufacturer.
Patel sees patients in the Washington 
University PrEP clinic on campus and also 
monitors patients at a pharmacy-based clinic in 
a neighboring strip mall. PrEP patients undergo 
quarterly checkups and receive HIV testing.
 “PrEP has been called the gateway to primary 
care for some at-risk populations. It’s important to 
seize this opportunity to connect this group with 
other prevention services,” Patel said.
Despite published research acknowledging 
PrEP’s eectiveness, the drug is not widely 
prescribed. One-third of primary care physicians 
and nurses don’t know it exists, a 2015 CDC report 
found. PrEP programs are at various stages of 
implementation in the U.S., Canada and Australia, 
as well as clusters of countries across the globe.
At an international HIV research conference 
in 2016, Patel presented an analysis on missed 
opportunities for PrEP. Based on surveys of 102 
patients in St. Louis, her research found two-
thirds had asked their primary care physicians for 
PrEP but were not prescribed it. e physicians 
cited discomfort with discussing the medication, 
in part, because they knew little about it. 
“Many physicians see PrEP as unnecessary 
because they believe their patients can just use a 
condom to prevent HIV,” Patel said. “But condoms 
are not 100 percent eective. e best scenario is 
to use both a condom and PrEP because, together, 
the likelihood of contracting HIV is miniscule.”
TOP: Bill Powderly, MD, right, holds an Outlook magazine 
cover from summer 2001 featuring his work with the 
multidrug “cocktails” then prescribed for patients living with 
AIDS. Rupa Patel holds the single daily pill called PrEP that 
now can help prevent HIV infections. Bottom: Therapies for 
HIV and AIDS have grown increasingly manageable.
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As the mysterious AIDS epidemic gripped the world in the 1980s, 
scientists at the School of Medicine 
went to work, contributing to 
groundbreaking research on HIV, 
as well as treatments such as the 
highly active antiretroviral therapy, 
commonly known as the AIDS  
drug cocktails.
In 1985, Lee Ratner, MD, PhD,  
the first to sequence HIV while at  
the National Institutes of Health 
(NIH), joined the School of Medicine 
and helped to steer HIV/AIDS 
research to prominence. 
More than three decades later, 
Ratner, the Alan A. and Edith L. 
Wolff Professor of Oncology, is 
internationally renown for his 
research on HIV and AIDS-related 
cancers and has been involved in 
dozens of clinical trials affiliated 
with the NIH’s AIDS Malignancy 
Consortium.
In 1987, Washington University 
expanded its research opportunities 
by establishing the AIDS Clinical  
Trials Unit (ACTU), part of a prestigious 
national network known collectively 
as the AIDS Clinical Trials Group and 
funded by the NIH.
“Since the beginning of the AIDS 
epidemic, Washington University 
has been a significant, productive 
contributor to HIV/AIDS research 
and treatment therapies,” said David 
B. Clifford, MD, ACTU director and 
the Melba and Forest Seay Professor 
of Clinical Neuropharmacology 
in Neurology. “Research here and 
worldwide is leading toward a cure 
for AIDS. Not long ago, I would 
have thought it improbable. But the 
science is moving forward.”
At Washington University’s 
ACTU, approximately 20 studies are 
underway examining all aspects 
of the disease. Clifford is leading 
research on whether statins reduce 
heart attacks and strokes in HIV 
patients, who are more likely to 
develop heart disease than people 
without the virus. “The study is 
looking at starting the drugs earlier 
than in the general population for 
our HIV patients in an effort to reduce 
these complications,” Clifford said.
Former ACTU Director William G. 
Powderly, MD, was a key researcher in 
evaluating the AIDS cocktail drugs, a 
concoction that decreased viral levels 
so patients could live longer. More 
recently, his research has focused on 
understanding long-term side effects 
of HIV medications, particularly 
metabolic problems such as diabetes, 
lipid abnormalities and osteoporosis.
“From a scientific perspective, it 
is incredible that over the past 30 
years, the AIDS epidemic went from 
a deadly disease to a preventable, 
manageable and chronic disease,” 
Powderly said.
Moving science forward 
Researchers propel AIDS from death sentence to chronic disease
Over the past 30 years,
David B. Clifford, MD, left,
and Lee Ratner, MD, PhD,
have conducted ground-
breaking research on
HIV, AIDS and related
treatments.
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A craving for ice cream recently led Patel to 
Boardwalk Waes & Ice-Cream, a new eatery in a 
trendy, LGBTQ-friendly St. Louis neighborhood.
“Can I hang a PrEP information poster here?” 
Patel asked co-owner Keith Cotton.
Patel chatted with Cotton about business, 
everyday life and PrEP. “I want you to know about 
PrEP in case customers see the poster and ask about 
it,” Patel said, eating an ice cream wae.
Patients and colleagues agree that Patel’s 
blunt, yet empathetic, approach is a key strength 
in helping patients. It’s one she learned before 
graduating from medical school. In 1999, her 
17-year-old brother came out as gay. “I went to 
LGBTQ dance clubs with him and immersed 
myself into his world to gain insight into what  
he was going through,” Patel said.
“My experience with my brother showed me 
how to approach communities at risk for HIV, 
de-medicalize or de-stigmatize sexual health, and 
create a clinic environment that oers more support 
and comfort for individuals.
“Washington University continues to be at the 
forefront of ending HIV because its physicians 
combine compassion with outstanding research.”
...Continued from page 13
More people at high risk for HIV would  
take PrEP if they understood it better, said Matt 
Swango, 39, a social worker at Saint Louis Eort 
for AIDS who works with Patel on PrEP outreach. 
“Many people say PrEP has taken the fear out of 
sex so they are able to get on with their lives,” he 
said. “It’s incredible if you compare it to the 1980s 
when people were literally dying in the streets. 
Younger people may not realize how far we’ve come 
because they’ve always lived in a world with AIDS.”
Critics cite concerns such as PrEP’s lack of 
protection against sexually transmitted diseases as 
well as its dependence on people remembering to 
take a pill every day. ere also is fear that PrEP 
will increase sexual promiscuity; however, studies 
have shown otherwise.
“One of PrEP’s biggest obstacles is a major 
reluctance to talk about sexual practices and 
sexual health in our society,” Patel said. “Men who 
are having sex with men may feel uncomfortable 
talking to a physician while physicians do not 
always view it as their role to discuss sexual 
health. Some never ask about a patient’s sexual 
preferences. is is a missed opportunity to 
identify a person who may be at risk for HIV.”
Talking frankly about sex
Patel never misses an opportunity to discuss 
PrEP, said Dave Rueschho, 35, one of Patel’s 
patients who takes PrEP as “an additional layer  
of security regarding HIV prevention.”
Rueschho, who helps Patel with PrEP out-
reach and serves as a member of the community 
advisory board for the PrEP injection study, said 
Patel has a special talent for connecting with 
others. “She is caring and genuinely respects all 
individuals,” he said. “Dr. Patel knows her patients’ 
culture and asks about their lives. She uses 
LGBTQ (lesbian, gay, bisexual, transgender and 
queer) language to assess risky sexual behaviors. 
She is not judgmental about anything people tell 
her and that makes them feel comfortable opening 
up to her. Talking explicitly about sex does not 
faze her.”
Indeed. Patel distributes PrEP yers everywhere 
she can, visits LGBTQ nightclubs and bathhouses 
to educate owners about PrEP, advertises on social 
media and coordinates community outreach 
through events and LGBTQ phone apps.
Preventing HIV infection: 
1. The body can fight off and 
destroy most germs (purple) 
before they replicate, but 
HIV (green) infects immune 
cells called T cells.  2. HIV uses 
reverse transcriptase to rapidly 
copy itself inside the T cell. 
The T cell bursts, causing the 
virus to spread.  3. PrEP is a 
combination of two medica-
tions called emtricitabine and 
tenofovir disoproxil fumarate, 
which are nucleoside reverse 
transcriptase inhibitors. These 
two medications block the 
virus from entering the body’s 
immune cells and, thus, pre-
vent HIV infection.
Germ1
2 3
HIV virus
T-cell
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An Air Force trauma team is 
activated at Bagram Air Base 
in Afghanistan.  
16  Washington University School of Medicine
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In a war zone in Afghanistan, a roadside bomb explodes 
and shrapnel tears through a U.S. soldier. e blast  
hurls him to the ground, and blood begins to ow  
from multiple wounds.
e soldier described here — a composite based on 
actual cases — faces a terrifying prospect: losing too 
much blood to survive before making it to a medical 
center. Bleeding out is the leading cause of potentially 
survivable deaths on the battleeld.
In this sandblasted combat setting, military medics 
must race to slow the bleeding and get the soldier to 
better-equipped facilities. To do this, they lean on skills 
they learned more than 7,000 miles away at Washington 
University School of Medicine prior to deployment. eir 
eorts are the rst step in a long chain of military actions 
that ultimately will bring the injured war ghter home.
Surgeons and researchers here are training military 
medics in frontline readiness, inventing ways to control 
and replace blood loss, and shaping U.S. military-civilian 
trauma care policies. ese eorts are positioning St. Louis 
as a national hub for research and control of traumatic 
bleeding, which could save not only lives like the soldier’s, 
but that of civilians, too.
Battleeld 
to bedside
Outlook  17
High-intensity military medicine spurs
innovations for civilians, too.
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When the wounded soldier in Afghanistan is stable enough to move, a helicopter ies him to  
the next triage station: a tent hospital with 
equipment stored in canvas bags for easy  
transport in an emergency. 
Doctors invoke a “walking blood bank,” 
and military personnel pre-screened for blood 
donation rapidly assemble. Within 30 minutes, 
one unit of whole blood is collected, and then 
transfused to the patient, while a surgical team 
works to control the bleeding. 
Pre-deployment  
trauma training
Before entering the war zone, many of these 
medical practitioners were trained in situations 
that mimic battleeld conditions — and they did  
it in St. Louis. e School of Medicine is the 
newest partner, along with the U.S. Air Force  
and SSM Saint Louis University (SLU) Hospital,  
in a national program called the Center for 
Sustainment of Trauma and Readiness Skills 
(C-STARS). 
In C-STARS, military medical technicians, 
nurses and doctors undergo 19 two-week 
sessions yearly at one of ve national training 
sites. Covered topics include: care under re, 
pre-hospital triage, hemorrhage control and the 
particulars of air evacuation. In short, medics  
are trained to use the latest eld-ready  
innovations to sustain life. 
When these physicians and medics are not 
deployed to a war zone, they may work in private 
practice or be reservists on military bases in the 
U.S. eir daily work typically is nothing like a 
war hospital. Yet, next year or the year aer, they 
may get redeployed and thrown into situations 
Col. Gerald Fortuna, MD, director of the C-STARS  
program and a vascular surgeon at the medical  
school, leads a REBOA training exercise. Developed 
by the military, REBOA (Resuscitative Endovascular 
Balloon Occlusion of the Aorta) is a relatively new 
blood-control technique only available at a handful 
of medical institutions. Using an ultrasound wand, 
trauma medics can guide placement of a catheter 
into the femoral artery and inflate a balloon to 
block the blood vessel. That way, a patient’s heart 
can still pump blood to the brain, without pumping 
it out of the open wound.
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“But there are things we do that are going to help 
them. It’s an exchange. It really is a partnership.
“ese are women and men who put their lives 
on the line, and develop the casualty programs 
that take care of our troops. If we can help in 
keeping their skill levels at the highest level, well, 
that’s a way for us to give back, frankly.” 
How to save a life
As part of the care continuum, the wounded 
soldier in Afghanistan is moved again — from 
the austere tent to a Combat Support Hospital at 
Kandahar Air Base. 
Aer another surgery, he ies on a cargo plane 
to Landstuhl, Germany, home of the only Level 
1 trauma center not on U.S. soil to be certied 
by the American College of Surgeons. e next 
day, teams of medics and military workers ready 
the soldier for his ight across the Atlantic 
Ocean. Injured U.S. troops ultimately are sent to 
Walter Reed National Military Medical Center in 
where they need to be at the top of their game.
“It’s easy for skills to erode if you spend too 
much time at your home base,” said Col. Gerald 
Fortuna, MD, director of the St. Louis C-STARS 
program and a vascular surgeon newly recruited 
to the School of Medicine. He holds joint 
appointments at Washington University and Saint 
Louis University. 
“Back at home, the No. 1 surgical procedure in  
our hospitals is delivering babies,” he said. “at’s 
drastically dierent than being over in Iraq or  
Afghanistan, where we’re seeing traumatic amputees, 
burns, multiple high-velocity gunshot wounds. 
When we go downrange,” — military term for 
deployment — “everything gets turned upside down.”
Washington University’s partnership with 
C-STARS ensures new training opportunities 
in this arena, even as the armed forces wind 
down their involvement in countries such as 
Afghanistan and Iraq, Fortuna said.
While St. Louis’ busiest hospital — Barnes-
Jewish — is no battleeld, the principles of high-
intensity emergency medicine are the same, said 
Timothy J. Eberlein, MD, the Bixby Professor of 
Surgery and head of the Department of Surgery. 
Barnes-Jewish cares for about 13,000 trauma 
patients each year, with a 99 percent survival rate.
“Not many of us get exposed to high-percussive 
bombs and armor-piercing bullets like our troops 
do,” Eberlein said. “But it’s the principles that we 
all benet from: How do you stem blood loss? 
How do you treat the person who has had multiple 
traumatic injuries? How do you quickly get them 
out of the eld and into a triage of care, in a 
stepwise progression?” 
St. Louis is the oldest C-STARS site, established 
15 years ago in partnership with SLU. With 
Washington University’s entry into the program, 
C-STARS can leverage the medical school’s many 
strengths, Eberlein said. Training now takes place 
on both campuses, and Washington University has 
plans to recruit more emergency physicians and 
trauma surgeons in connection with the program.
Eberlein added that the medical school has 
a long track record of translational research 
on acute and critical care, trauma surgery and 
cooperation with the U.S. Defense Department, 
plus a strong research program focused on 
traumatic bleeding. 
 “C-STARS brings concepts from the military 
that we can adapt, and it makes Washington 
University and the Department of Surgery better,” 
said Eberlein, who lobbied for the collaboration. 
Timothy J. Eberlein, MD, center, head of the Department of 
Surgery, leads a cohort of military personnel on a tour of the 
Medical Campus. Above, Maj. Gen. Robert D. McMurry Jr., 
left, and Brig. Gen. Mark A. Koeniger. 
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Bethesda, Maryland; Brook 
Army Medical Center in San 
Antonio; or Balboa Naval 
Medical Center in San Diego. 
“With the whole operation 
running, it would not be 
uncommon for somebody to 
be injured on the battleeld 
and wake up in 72 hours 
in the U.S., having received 
three, four or ve operations 
in that time,” said Fortuna, 
who served two tours of duty 
in Afghanistan. It’s one reason 
why, in the most recent conict in Afghanistan and 
Iraq, the U.S. armed forces experienced the lowest 
case fatality rate in the history of modern warfare, 
he said. 
“If you made it o the battleeld, and made it 
to that tent hospital with a surgeon, your survival 
rate was over 98 percent. We were actually 
exceeding civilian hospitals, and with a higher 
acuity level,” Fortuna said.
It wasn’t always this way. Almost one-fourth of 
Americans who died in conict during the past 
decade perished from wounds they might have 
survived given the proper care, according to a 
report from the military’s Joint eater Trauma 
During Operation Iraqi  
Freedom in Baghdad,  
critical care doctor Phil 
Spinella, MD, right, first 
became interested in 
the efficacy and safety 
of blood products for the 
treatment of shock. 
“It’s not intended to replace 
human transfusion, but to push 
transfusion capability into more 
austere settings.” 
                                          — Allan Doctor, MD
System. is nding led the secretary of defense to 
impose standards for pre-hospital transport times 
in an eort to reduce death from severe bleeding. 
Hemorrhagic shock is dened as a loss of more 
than 20 percent of the body’s blood supply. At its 
most basic level, bleeding occurs because blood 
vessels have ruptured. Injury, surgery, childbirth, 
infections and cancer therapy all can cause or 
promote serious bleeding. In the U.S., about 
30,000 people die each year from preventable  
conditions aer their initial injury, oen due to 
inadequate therapies or untimely access to care.
If physicians can stop this bleeding, seal torn 
vessels and replace lost blood, they can save a 
person’s life. Washington University researchers 
are searching for novel ways to do this, including 
improved blood products, articial blood and 
blood-clotting mechanisms.
The case for whole blood
During Operation Iraqi Freedom in 2004, critical 
care doctor Phil Spinella, MD, and his Army 
colleagues couldn’t wait any longer for blood supplies 
to arrive in Baghdad. ey rolled up their sleeves 
and gave their own blood directly to the casualties. 
Surprisingly, it worked better; hemorrhagic shock 
20  Washington University School of Medicine
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resolved sooner in patients 
receiving whole blood versus 
separated blood components 
(platelets, red blood cells and 
plasma) shipped from home.  
“When you take blood and 
split it into components, it’s 
much more diluted. at aects 
blood’s ability to stop bleeding 
and to carry oxygen,” said 
Spinella, who served as active-
duty Army for 12 years, earning 
the Bronze Star and Combat 
Medic Badge for providing care 
under re. 
It was during this 
deployment that Spinella 
became interested in the ecacy 
and safety of blood products for 
the treatment of shock. 
Today, he is director of 
the Pediatric Critical Care 
Translational Research Program at St. Louis 
Children’s Hospital, director of the Blood Research 
Program and professor of pediatrics. He studies 
transfusion outcomes in children and adults with 
severe bleeding and the eects of red blood cell 
storage times on recovery. 
Based on research and testimony provided by 
Spinella, the U.S. surgeon general issued changes 
supporting increased ratios of both plasma and 
platelets to red blood cell units for military 
casualties with severe hemorrhage. 
Nationally, Spinella has been a vocal advocate  
for trauma care improvements. As part of a 
National Academy of Sciences committee, he 
helped write a 400-page report to ensure that 
lessons learned from the military’s experiences  
in Afghanistan and Iraq are integrated into  
future combat operations and into the civilian 
trauma system. 
And following the Boston Marathon bombing 
and resulting concerns about inadequate blood 
supplies in the wake of terrorist attacks, Spinella 
organized a full-day conference at the White 
House for the National Security Service. Spinella 
said he felt it was important to expose the fact  
that all major U.S. cities are at risk of running 
out of blood in any mass-casualty event. Most 
emergency preparedness eorts focus on 
evacuations, he said, not on the blood supply.  
He advocates a whole-blood program in which 
pre-screened donors could be alerted to report  
to U.S. collection centers.
Substitutes for real blood
For more than 80 years, researchers have searched 
for articial blood substitutes. e need is clear: 
in acts of mass violence, on the battleeld and in 
remote locations. Now, the School of Medicine is 
on the forefront in developing them. 
Researchers here believe that red blood cells 
— in a powdered form — might be available to 
trauma patients within 10 years. is powder 
could be stored in a backpack for a year or more 
and reconstituted with water when needed. By 
contrast, fresh blood can be stored for about 40 
days. Unrefrigerated, it only lasts a few hours. 
Allan Doctor, MD, professor of pediatrics, 
immediate past director of the Division of 
Pediatric Critical Care and associate professor of 
biochemistry and molecular biophysics, worked 
with Spinella, Gregory M. Lanza, MD, PhD, the 
Oliver M. Langenberg Distinguished Professor of 
Science and Practice of Medicine, and Dipanjan 
Pan, PhD, (now at the University of Illinois at 
Urbana–Champaign) to create an articial red 
blood cell that can pick up oxygen and transport it 
through the body, as a human red blood cell does. 
e articial cells, called ErythroMer, are made 
from puried hemoglobin, the oxygen-transporting 
component of red blood cells. e cells are freeze-
dried into a powdered form. A polymer coating 
Allan Doctor, MD, left, lead 
developer of ErythroMer, and 
research specialist Shivam Shah 
compare the vascular reactivities 
of artificial and real red cells. 
Emulating red cell physiology 
is a novel, unique feature 
distinguishing ErythroMer  
from other blood cell 
substitutes.
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EVARREST® Fibrin 
Sealant Patch
EVARREST contains two  
human biological components: 
fibrinogen and thrombin.  
When applied to a bleeding  
area, moisture causes the 
substances to react together, 
leading to rapid clot formation. 
In about eight weeks, the body 
absorbs the patch material. 
EVARREST does not require 
preparation, mixing, moistening 
with saline or refrigeration, and 
has a shelf life of 30 months.
TAMPITI trial
Tranexamic acic, or TXA, reduces  
the breakdown of clots that  
form with bleeding and has been 
shown to minimize blood loss 
in patients with hemophilia, 
a genetic clotting disorder. 
Researchers are evaluating  
the drug’s safety and optimal 
dosage in trauma patients. 
Patients who require at least 
one unit of blood or immediate 
transfer to an operating room  
are eligible for the trial.
ClotFoam® 
ClotFoam might help in cases 
in which a patient is bleeding 
so badly that compression of 
the wound doesn’t help, in the 
operating room and on the 
battlefield. When mixed and 
injected, the adhesive hydrogel 
spreads throughout the body 
cavity, sealing lacerated tissue 
and promoting clotting. The 
product’s technology generates  
a 3-D scaffold that carries a  
fibrin sealant.
ErythroMer  
This nanoparticle-based red 
blood cell picks up oxygen from 
the lungs and detects where it 
should be delivered based on 
the pH level of the blood. The 
cells are made from purified 
human hemoglobin and coated 
with synthetic polymer. As 
hemoglobin can cause blood 
vessel constriction — increasing 
the risk of heart attack and 
stroke — the coating is a key 
differentiator to past attempts. 
Innovations in blood control and replacement
New options buy time, increase the odds for trauma patients
22  Washington University School of Medicine
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is “immune silent” so anyone can accept the 
powdered blood cells regardless of blood type.
Of course, red blood cells perform many 
functions beyond carrying oxygen. Articial 
blood never will replace the real thing, but it  
can buy critical time for a wounded patient. 
“It’s not intended to replace human 
transfusion, but to push transfusion capability 
into more austere settings,” Doctor said. 
Clinical trials in small animals already have 
shown success, and the researchers are moving 
into larger animal studies. 
e researchers’ vision extends beyond the 
battleeld. Such a substitute could be stored 
where people congregate — in stadiums, malls 
and other public venues that might fall under 
large-scale terrorist attacks.
Stopping the bleeding
Washington University researchers also are 
involved in a variety of blood-clotting innovations.
Spinella and Grant Bochicchio, MD, MPH,  
the Harry Edison Professor of Surgery and chief 
of the Section of Acute and Critical Care Surgery, 
are studying the use of a tranexamic acid, a 
blood-clotting drug that could improve survival.
e trial, Tranexamic Acid Mechanisms 
and Pharmacokinetics in Traumatic Injury 
(TAMPITI), received the rst consent exemption 
ever granted by the School of Medicine’s 
Institutional Review Board. Patients who arrive 
at Barnes-Jewish Hospital with traumatic injuries 
requiring transfusion are automatically placed 
in the trial, and informed that they received the 
drug aer they are stabilized. 
Sometimes a drug might not be enough to 
help clot a wound; in that case, the FDA-approved 
EVARREST patch could help. It looks like ordinary 
cotton gauze, but the patch contains blood-clotting  
agents, so it not only seals a wound, but also actively 
works to stop blood from owing, explained 
Bochicchio, who was involved in the development.
In addition, use of specialized foam to stop severe 
internal bleeding due to trauma is a step closer to 
reality, largely through Bochicchio’s eorts.
He is principal investigator of a phase I 
clinical trial evaluating the safety of ClotFoam. 
e foam, administered via an applicator device 
during surgery, binds to the bleeding site and  
lls the body cavity.
“at way, you can get the patient to a surgeon 
further aeld. It’s kind of like ‘x-a-at’ technology, 
if you will,” he said. Bochicchio also has worked 
at the R. Adams Cowley Shock Trauma Center in 
Baltimore, which is another C-STARS center.
Bochicchio and colleagues already have 
established the foam’s eectiveness in animals; 
their clinical trial evaluates safety and 
eectiveness in humans. 
In the future, a wounded soldier like the one 
in Afghanistan might face better odds because 
of technology and protocols developed or tested 
in St. Louis — from a transfusion of ErythroMer 
or whole blood, to the EVARREST patch and 
ClotFoam, to seamless triage and transport. 
While all these changes would improve a 
wounded war ghter’s chance of survival, the 
truth is that these advances benet civilians, too. 
Spinella said all types of patients could have better 
outcomes — adults and children alike, trauma and 
surgical patients and those with internal bleeding.
“is aects everybody, no matter who  
you are.”  
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Grant Bochicchio, MD, MPH, and a colleague assemble the device 
used to apply a specialized foam to control severe bleeding in 
trauma patients. Bochicchio is heading a clinical trial testing its 
safety and effectiveness in humans.
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Match Day
March 17, 2017
Eric P. Newman Education Center
On Match Day, thousands of graduating medical  
students across the country simultaneously find  
out where they will head for residency training.
With 137 graduating 
students, the Class of 2017 at Washington 
University is exceptionally large and also boasts 
an exceptional match rate  — 96 percent as compared  
to the national match rate of 94 percent.
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C A L I F O R N I A
Harbor-UCLA Medical Center
SURGERYPRELIMINARY
Anchal Bansal
O’Connor Hospital, San Jose
FAMILY MEDICINE
Daniel Weisel
Olive View-UCLA Medical Center
MEDICINEPRIMARY
Ana Rivera
Stanford University Programs
NEUROLOGICAL SURGERY
David Dadey
University of California-Davis
OPHTHALMOLOGY
Colin Bacorn
University of California-Irvine 
Medical Center
PSYCHIATRY
Jeffrey Leong
University of California- 
San Francisco
CHILD NEUROLOGY
Nehali Mehta
NEUROLOGY
Brandon Holmes
University of Southern California
EMERGENCY MEDICINE
Harleen Grewal
Ventura County Medical Center
FAMILY MEDICINE
Rachel Corbin
C O L O R A D O
University of Colorado School  
of Medicine-Denver
PEDIATRICS
Lyndsey Cole
C O N N E C T I C U T
Yale-New Haven Hospital
MEDICINEPRIMARY
Arjun Gokhale
D I S T R I C T  O F  
C O L U M B I A
Georgetown University Hospital
INTERNAL MEDICINE
Michael Yang
I L L I N O I S
Northwestern McGaw/Lurie 
Children’s 
CHILD NEUROLOGY
Laura Bliss
PEDIATRICS
Sangitha Krishnan
Northwestern McGaw/NMH/VA
EMERGENCY MEDICINE
Abiye Ibiebele
INTERNAL MEDICINE
Chetan Vakkalagadda
NEUROLOGY
Jordan Standlee
Mengxuan Tang
OBSTETRICSGYNECOLOGY
Miriam Ben Abdallah
I N D I A N A
Indiana University  
School of Medicine
EMERGENCY MEDICINE
Nicole Benzoni
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L O U I S I A N A
Tulane University School  
of Medicine
MEDICINEPEDIATRICS
Priya Pal
M A S S A C H U S E T T S
Brigham & Women’s Hospital 
(BWH)
ANESTHESIOLOGY
Frances Wallace
INTERNAL MEDICINE
Nicholas Semenkovich
RADIOLOGYDIAGNOSTIC
Yuntong Ma
Shruti Mishra
Massachusetts General Hospital
ANESTHESIOLOGY 
Jenny Zhao Cheng
Hilary Gallin
EMERGENCY MEDICINE  
BWHHARVARD
Anita Chary
INTERNAL MEDICINE
Janice Kim
Joseph Planer
Sathish Subramanian
M I C H I G A N
Detroit Medical Center/Wayne 
State University
EMERGENCY MEDICINE
James VandenBerg
University of Michigan Hospitals
UROLOGY
Robert Wang
Western Michigan University/
Stryker School of Medicine
EMERGENCY MEDICINE
Nicholas Vryhof
M I N N E S O T A
Mayo Clinic School of  
Graduate Medical Education
INTERNAL MEDICINE
Vanessa Kronzer
University of Minnesota  
Medical School
RADIATION ONCOLOGY
Colton Gits
M I S S O U R I
Barnes-Jewish Hospital
ANESTHESIOLOGY
Austin Lohse
DERMATOLOGY
James Ko
EMERGENCY MEDICINE
Julia Lange
INTERNAL MEDICINE
Stephen Fuest
Taylor Geisman
Tracey Godbold
Shannon Hritz
Jordan Jacquez
Andrew Jallouk
Kevin Li
Charlotte Lin
Michael Madigan
David Russler-Germain
Ching-Chieh Shen
Michael Slade
Abby Sung
Debra Yen
Diana Zhao
James Zou
MEDICINEPRIMARY
Randy Laine
Zhe Liang
NEUROLOGICAL SURGERY
Kevin Cross
Carl Hacker
NEUROLOGY
Matthew Brier
OBSTETRICSGYNECOLOGY
Allison Schelble
OTOLARYNGOLOGY
Miranda Lindburg
S. Andrew Skillington
PATHOLOGY
Lily Zhang
PLASTIC SURGERY  
INTEGRATED
Andrew Linkugel
PSYCHIATRY
Tingying Chi
Giuseppe D’Amelio
Baris Ercal
Timothy Laumann
RADIOLOGYDIAGNOSTIC
Jodie Chang
Michael Lanier
Qi Xiao
RADIOLOGYDIAGNOSTIC/
RESEARCH
Matthew Glasser 
SURGERYPRELIMINARY
Martha McGilvray
VASCULAR SURGERY
Katherine Holzem
St. Louis Children’s Hospital
CHILD NEUROLOGY
Jordan Cole
PEDIATRICS
Ari Berlin
Miquia Henderson
Amanda Reis
Ellen Schill
Saint Louis University School  
of Medicine
OBSTETRICSGYNECOLOGY
Bree Porcelli
RADIOLOGYDIAGNOSTIC
Alisa Tanakit
Francis Wu
Washington University
OPHTHALMOLOGY
Jennifer Enright
N E W  J E R S E Y
Rutgers-New Jersey  
Medical School
GENERAL SURGERY
Arith Ruth Reyes
N E W  Y O R K
Hofstra Northwell School  
of Medicine
DERMATOLOGY
Amy Xu
Hospital for Special Surgery
ORTHOPAEDIC SURGERY
Tony Shen
Icahn School of Medicine at 
Mount Sinai
OBSTETRICSGYNECOLOGY
Lindsay Burton
Jacobi Medical Center/Einstein 
College of Medicine
PEDIATRICS
Rachel Stern
Memorial Sloan Kettering 
Cancer Center
RADIATION ONCOLOGY
Ishita Chen
Xiaojing Huang
Monteore Medical Center-
Einstein Campus
INTERNAL MEDICINE
Nai Chien Yeat
OBSTETRICSGYNECOLOGY
Asante Badu
RADIOLOGYDIAGNOSTIC
Sean Boone
New York Presbyterian  
Hospital-Columbia University 
Medical Center
PEDIATRICS
Carol Shen
N O R T H  C A R O L I N A
Duke University Medical Center
ANESTHESIOLOGY
Rosie Tang
INTERNAL MEDICINE
Daphne Xiao
MEDICINEPEDIATRICS
Austin Wesevich
University of North Carolina 
Hospitals
ORTHOPAEDIC SURGERY
Karly Lorbeer
O H I O
Cleveland Clinic Foundation
ANESTHESIOLOGY
Shari Oesterreich
Ohio State University  
Medical Center
EMERGENCY MEDICINE
Christine Luo
University of Cincinnati  
Medical Center
OTOLARYNGOLOGY
Sonia Yuen
P E N N S Y L V A N I A
Albert Einstein Medical Center
EMERGENCY MEDICINE
Elizabeth Rosenberg
Allegheny General Hospital
EMERGENCY MEDICINE
Anna Moseley
Emily Moseley
Children’s Hospital of  
Philadelphia
PEDIATRICS
Ashley Osborne
Hospital of the University of 
Pennsylvania
EMERGENCY MEDICINE
Rachel Gartland
Gregory Rippberger
INTERNAL MEDICINE
Abraham Segura
MEDICINEPEDIATRICS
Kenneth Macneal
NEUROLOGY
Jessica Fan
ORTHOPAEDIC SURGERY 
Agnes Dardas
Thomas Jeerson University
ORTHOPAEDIC SURGERY
Brandon Rogalski
University of Pittsburgh  
Medical Center 
INTERNAL MEDICINE/ABIM  
RESEARCH PATHWAY
Edwin Chen
Sunmin Park
PEDIATRICS
Chinwe Madubata
T E N N E S S E E
Vanderbilt University  
Medical Center
OBSTETRICSGYNECOLOGY
June Wang
T E X A S
Baylor College of Medicine-
Houston
ORTHOPAEDIC SURGERY
Aalok Patel
PEDIATRICS
Alejandro Siller
University of Texas Medical 
School-Houston
UROLOGY
Nathaniel Coddington
University of Texas Southwestern  
Medical Center
INTERNAL MEDICINE
Ethan Tobias
OBSTETRICSGYNECOLOGY
Kelly Milman
W A S H I N G T O N
University of Washington  
Aliated Hospitals
OBSTETRICSGYNECOLOGY
Nicole Kretzer
PEDIATRICS
Lucy Bollinger
Jennifer Duong
PLASTIC SURGERY  
INTEGRATED
Jenny Yu
W I S C O N S I N
Mayo Clinic School of  
Graduate Medical Education
FAMILY MEDICINE
Jared James
Medical College of Wisconsin 
Aliated Hospitals
PLASTIC SURGERY  
INTEGRATED
Miles Bichanich
University of Wisconsin  
Hospital and Clinics
OBSTETRICSGYNECOLOGY
Melissa Meyer
C A N A D A
University of Calgary
ORTHOPEDIC SURGERY
Michael James
Choosing to defer residency:
Paul Gamble
Arthur Lee
Tara Rao
See more photos online:
wumcnews.org/match2017
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Caring  
for mom 
& baby
Children’s outcomes 
improve when perinatal 
mental health issues are 
addressed.
Robin Torrence-Webber was thrilled 
when, 
at 37, she became pregnant with her second 
child. But a diagnosis of preeclampsia and 
an emergency caesarian section at 23 weeks presented 
a dicult reality. Babies generally are not considered 
medically viable before 24 weeks of gestation.
She woke to learn that her newborn son, Baby Ray 
Webber III, who weighed just 1 pound, 1.6 ounces, 
had been taken from Barnes-Jewish Hospital to  
St. Louis Children’s Hospital, where doctors were 
trying to save his life.
26  Washington University School of Medicine
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From left, Robin Torrence-
Webber with her son, Baby 
Ray, and therapist Anna  
Constantino-Pettit, MSW ‘14.
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ree days later, Torrence-Webber nally got to see her 
baby. “He was so little,” she said. “He could literally t in 
the palm of my hand.” Torrence-Webber spent days and 
nights at the neonatal intensive care unit (NICU),  
not knowing if her son would survive. 
While Ray clung to life, Torrence-Webber grew more 
anxious and depressed. She was torn between taking care  
of her daughter at home and visiting Ray in the NICU.  
“I was having anxiety attacks,” she said. “I couldn’t  
sleep. I couldn’t function.” 
Torrence-Webber sought help aer NICU sta told her 
about the Perinatal Behavioral Health Service (PBHS) at 
the School of Medicine. e PBHS oers counseling and 
psychiatric care for pregnant women and new mothers  
with anxiety or depression.
Physical, emotional toll on baby 
Fieen percent of women experience perinatal anxiety or 
depression. Although women with a history of psychiatric 
disorders are predisposed to the condition, it can strike 
anyone. For women with babies in the NICU, the number 
jumps to 40 percent. Parents of babies in the NICU 
undergo enormous stress and oen face unaddressed 
mental health issues. 
Cynthia Rogers, MD, one of the PBHS founders, 
determined that by setting up services to treat these 
mothers, she could improve the outcomes of their children.
Rogers, an assistant professor of child psychiatry, has 
studied how exposure to a parent with behavioral health 
issues aects brain development in young children, 
increasing the likelihood of childhood psychiatric disorders.
Le untreated, such issues can aect a child physically 
and emotionally, beginning in the womb. Studies suggest 
that the mother’s physiology during pregnancy can change 
the baby’s physiology. 
Elevated levels of the stress hormone cortisol, common 
in depressed patients, are believed to aect development of 
a part of the brain called the amygdala. Other research has 
revealed dierences in the thickness of the cerebral cortex 
between infants of depressed mothers and a control group. 
Behaviorally, such infants are at increased risk for fussiness, 
failure to thrive, and developmental delay at 1 year of age. 
Mental health issues also aect how moms are able to 
care for and interact with their children. “Mothers with 
untreated mood disorders are less likely to engage in a 
host of nurturing behaviors proven to promote healthy 
development and attachment, including breastfeeding, 
being emotionally responsive and aectionate, reading,  
and singing to babies,” Rogers said.
Moreover, studies have shown that children whose 
parents have untreated mental health issues are at much 
greater risk to experience abuse and neglect. As they grow, 
these children are more likely to develop mental issues such 
as depression and attention decit/hyperactivity disorder.
“When you don’t treat moms, you see a signicant 
impact on child mental health, academic performance  
and many other outcomes,” Rogers said.
Serving a critical need
Rogers began treating parents of NICU babies in 2010 
— rst by meeting them in the NICU, and later via a 
Children’s Hospital clinic. She realized, over time, that these 
families needed more help than she alone could provide.  
As a child psychiatrist, Rogers’ schedule already was full.
At the same time, Kelly Ross, MD, assistant professor 
of pediatrics, was searching for a way to help anxious  
and depressed mothers who had delivered babies at 
Barnes-Jewish.
Rogers and Ross joined forces to create the Perinatal 
Behavioral Health Service in 2012. ey chose the term 
“perinatal” rather than “postpartum” because the PBHS 
works with both new mothers and pregnant women, who 
are also at increased risk for depression. 
Supported by grants and private philanthropy, the 
PBHS is a team of social workers, psychiatrists and 
psychologists who oer testing, counseling, medication 
and case management. 
Cynthia Rogers, MD, right, co-founder of the Perinatal Behavioral Health Service, 
discusses the progress of infant Tycen Reisch with his mother, Stacy Reisch.
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e service screens women for anxiety, depression and 
trauma at multiple locations, including the maternity 
oors at Barnes-Jewish, the NICU at St. Louis Children’s 
Hospital, and the Obstetric Clinic at the Barnes-Jewish 
Center for Outpatient Health. e service also accepts 
community and self-referrals.
In Missouri, obstetrician-gynecologists commonly screen 
new mothers for depression at the six-week postpartum 
checkup. Because mental illness can aect a mother’s ability 
to bond, PBHS screenings take place as early as eight weeks 
of pregnancy — potentially improving those rst mother-
child interactions. Rogers said women need to understand 
that mental health issues, such as anxiety and depression, 
occur commonly in pregnancy and in those oen-grueling 
months aer bringing home a newborn.   
Screening is particularly important because, all too oen, 
mothers of newborns are afraid to admit they are unhappy.
 “Everybody believes that the experience of childbirth 
is supposed to be an ecstatic experience,” Rogers said. 
“So when that doesn’t happen, women feel that there is 
something wrong with them, or that they’re bad mothers.” 
Learning to adjust
Torrence-Webber developed coping skills through  
weekly sessions in the NICU with PBHS therapist  
Anna Constantino-Pettit, MSW ’14. “Anna lied  
my spirits,” she said.  
Talking to Constantino-Pettit helped ease Torrence- 
Webber’s guilt as she split her time between Baby 
Ray and family at home. At her therapist’s suggestion, 
Torrence-Webber began meditating and writing in a 
journal. Constantino-Pettit also taught Torrence-Webber  
to be mindful of situations that trigger negative feelings.
Perhaps most importantly, Constantino-Pettit  
provided Torrence-Webber a safe space to talk about  
her diculties without being judged. 
At 8 months of age, Baby Ray was ready to come home. 
Despite much progress, his homecoming presented new 
challenges. “I went from having 24-hour nursing care 
to taking care of a baby who’s on oxygen and a heart 
monitor,” Torrence-Webber said. 
Once again, Torrence-Webber realized she needed  
help to adjust to the new routine. She and Constantino-
Pettit resumed their sessions. Today, Torrence-Webber  
has successfully adjusted to caring for Baby Ray.
Hundreds of families have been helped through the 
PBHS, and Rogers remains passionate about its mission.
“Seeing parents who, even aer a dicult start, 
are raising emotionally healthy children is the most 
worthwhile outcome I can think of,” she said.
One St. Louis couple with firsthand knowledge of  postpartum depression is boosting the efforts of the 
Perinatal Behavioral Health Service (PBHS). Mary Steward and 
David Steward II are committed to helping mothers and babies 
get off to the best possible start. 
With a generous 
gift from the Steward 
Family Foundation, 
the couple created 
the Steward Family 
Perinatal Behavioral 
Health Service Fund 
to provide necessary 
support. The gift helps 
high-risk families that 
might not otherwise 
have access to mental 
health resources. At 
Barnes-Jewish Hospital, 
for example, many 
expectant moms are uninsured or on Medicaid.
The Stewards learned about the PBHS while touring the 
medical school. They immediately were struck by how early 
intervention can translate into lifelong benefits for  
moms and their kids.
 “We like the proactive aspect of the service,” said Mary 
Steward. “It’s not waiting around for something awful to 
happen, but getting women help on the front end.
“To not allow someone to be lifted out of that state and 
have a great experience with her child because she doesn’t 
have access to proper medical care or prescriptions — we  
just can’t allow that to happen,” she added.
The subject hits close to home: Mary Steward recalls the 
exhaustion and isolation she felt several weeks after the 
birth of her first child. Whether her depression was caused by 
hormonal changes, being cooped up during a bleak winter, or 
the transition to full-time motherhood, she said she knew that 
something was wrong.
“It was apparent that it wasn’t just the normal ‘I just  
had a baby and I’m a little tired from getting up in the middle 
of the night,’” Mary Steward said. She confided in loved ones, 
who encouraged her to seek medical care. The treatment 
was effective, and, in talking openly about the problem, the 
Stewards realized that so many others are affected. 
“We hope that our support will help make programs like  
this the standard of care,” David Steward II said. “It’s so 
important that women across cultures realize that this is a 
common condition that can be treated.” 
Mary and David Steward
Gift strengthens services 
for high-risk families
Spring 2017
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For information on establishing a scholarship at 
the School of Medicine, contact Medical Alumni 
and Development at (314) 935-9686 or  
medicalannualfund@wustl.edu. 
To give securely online, visit  
medicalalumni.wustl.edu/give.
Brookings 
Partners 
Through bequests or  
planned gifts 
Eliot  
Society  
500 new or upgraded  
memberships
T H E  G O A L
In gratitude for financial support and training opportunities that Bob Warren, MD/PhD ’78, MPH, received at the School of Medicine, he and wife Nancy 
Warren, PhD, are challenging fellow alumni to give  
back to Washington University. e couple has issued 
a $500,000 William Greenleaf Eliot Society Challenge 
dedicated to scholarships.  
e challenge continues a long tradition of alumni 
helping future students. Scholarships and nancial aid 
enable Washington University School of Medicine students 
to graduate with average debt of $97,000 — well below the 
national average of $180,000. 
“If we can encourage 500 people to join us, together we 
can make a signicant dierence in the lives and careers of 
medical students,” said Bob Warren. 
“Nancy and I have been members of the Eliot Society for 
many, many years. We’re delighted that we can now help  
more than we ever imagined with an additional estate gi. 
We hope alumni will accept our challenge and join us now 
as members of the Eliot Society, and also consider becoming 
Washington University Brookings Partners with an estate gi.” 
All unrestricted gis to the university of $1,000 or more 
qualify the donor for membership in the Eliot Society. Eliot 
Society donations support scholarships, student assistance 
programs, educational resources, faculty development and 
recruitment, and other initiatives.
e challenge runs through June 30, 2018, the conclusion 
of Leading Together: e Campaign for Washington University. 
“We want our fellow alumni to reect upon what their 
experiences in medical and graduate school at Washington 
University have meant to them and their families,” Bob 
Warren said. “e extraordinary medical education  
I received catalyzed my professional life,” he added.  
 “e nancial support Bob received while he was in  
the Medical Scientist Training Program and I was getting  
Take the Warren Challenge and transform the lives of medical students
my doctorate in psychology 
from Saint Louis University  
was transformative,” said  
Nancy Warren. 
In particular, being free  
from medical school debt 
enabled the pair to pursue 
careers in academic medicine. 
In his roles as division chief 
of pediatric rheumatology and 
immunology at the University of 
North Carolina at Chapel Hill 
(UNC) and as chief of pediatric 
rheumatology at Baylor  
College of Medicine in Texas, 
Bob Warren trained hundreds of physicians in the rare 
specialty of pediatric rheumatology.  He also championed 
caring for chronically ill children via a team approach, which 
included family members and other health-care practitioners. 
Similarly, while on the faculties of both UNC and Baylor, 
Nancy Warren developed transition programs to help family 
members cope with crises or a loved one’s mental illness. 
In addition to treating patients, Nancy now teaches at the 
Medical University of South Carolina in Charleston.
Bob Warren is still focused on quality of care, but mostly 
from a dierent angle. He is now the chief medical information 
ocer at the Medical University of South Carolina. He 
continues to see children with rheumatic diseases.
Reecting on their path, Bob and Nancy Warren want to 
support and transform the lives of young doctors in the same 
way they were helped.
Needed: 500 alumni
“ The financial support Bob 
received ... was transformative.”
Robert and Nancy Warren
Mary and David Steward
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classnotes
1960S 
Curtis J. Krock, HS 65, retired from  
full-time pulmonary practice in 2001. He 
served with the medical residency program 
at Carle Foundation Hospital in Urbana, Ill., 
until 2003 and, as interim chief of medicine 
at the University of Illinois at Urbana-
Champaign College of Medicine until 2005. 
Krock enjoys spending winters in  
San Francisco. 
1970S 
Toby L. Simon, MD 70, is senior medical 
director at global biotherapeutics firm CSL 
Behring and on the voluntary faculty at the  
University of New Mexico School of Medicine.  
He recently completed a four-year term as 
industry representative for the FDA Blood 
Products Advisory Committee. He is also 
senior editor of the recently published fifth 
edition of “Principles of Transfusion Medicine.”
Robert Weiss, MD 74, returned to Uganda 
for a second year of teaching, this time to 
Mbale, a city in Eastern Uganda. He is at a 
newly established university, teaching its first 
fourth-year (clinical) class. His wife is accom-
panying him as an assistant librarian at the 
university. Weiss retired from office practice 
with Cleveland Clinic in December 2015.
1980S 
Linda R. Struckmeyer, OT 82, recently 
earned a PhD in occupational therapy from 
Texas Woman’s University and was pro-
moted to clinical assistant professor in the 
Department of Occupational Therapy at the 
University of Florida.
Ellis J. Neufeld, MD/
PhD 85, has been 
appointed clinical 
director, physician-
in-chief and execu-
tive vice president 
of St. Jude Children’s 
Research Hospital, 
based in Memphis. 
In this role, Neufeld oversees the organiza-
tion’s academic clinical departments and 
all clinical operations. Neufeld previously 
served as associate chief of the Division 
of Hematology/Oncology at Dana-Farber/
Boston Children’s Cancer and Blood 
Disorders Center. He also was medical  
director at the Boston Hemophilia Center 
and held the Egan Family Foundation Chair 
in Transitional Medicine at Harvard Medical 
School as a professor of pediatrics.
1990S 
Gary Steven Solomon, LA 92, OT 93, is 
president of the American Society of Hand 
Therapists. He is manager of Chicago Metro 
Hand Therapy and works as a certified hand 
therapist. Solomon lives in Deerfield, Ill., with 
his wife Debbie (nee Handler), LA 93, OT 
94, and their two daughters, Ilana and Talia.
Bernadette Aulivola, MD 97, was 
appointed director of the Division of 
Vascular Surgery and Endovascular Therapy 
at Loyola University Medical Center in 
Maywood, Ill., this past July.
Parveen Chand, HA 98, has served as the 
chief operating officer at Indiana University 
Health-Academic Health Center, Adult 
Hospitals, in Indiana since August 2016.   
Find your friends.
Classnotes are organized first by  
year of degree/training completion 
and then in alphabetical order. 
How about you?
Share your news via the online 
form at wumcnews.org/classnotes. 
Submissions will be printed in 
a subsequent issue of Outlook 
magazine as space allows. Photos 
are welcome.
Beloved former professor turns 100
The second physician to complete a residency within the School of 
Medicine’s Division of Urologic  
Surgery (in 1949) celebrated his  
100th birthday in March. 
Robert Royce, MD ’42, HS ’49, was 
on the medical school faculty for 45 
years, including a three-year stint as 
head of the urologic surgery division 
and 15 years leading its residency 
program. Teaching, Royce said, was  
one of the great joys of his career.  
To honor his legacy as a beloved 
professor, in 2010, the division 
created the Robert Killian Royce, MD, 
Distinguished Professorship in Urologic 
Surgery. Gerald L. Andriole Jr., MD, 
holds the professorship.
Although retired from medicine for 25 years, Royce remains active. Among his 
favorite pastimes: riding an all-terrain vehicle on his ranch, golfing, hiking, playing 
poker and spending time with friends, children and grandchildren. “I can’t believe I’ve 
been so lucky,” he said. “I’ve had a heck of a lot of fun in my life, and I’m still having fun.”
Royce lives in St. Louis.
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Jonathan Chung, MD 04, recently started 
a new job at The University of Chicago 
Medicine as associate section chief of thoracic 
imaging and associate professor of radiology.
Valencia Gant, HA 07, SW 07, was  
promoted to assistant director of ambula-
tory surgery services for Texas Children’s 
Hospital The Woodlands.
Shandiz Tehrani, MD/PhD 08, is an  
assistant professor of ophthalmology at 
Oregon Health & Science University, where 
he specializes in the clinical and surgical care 
of adult glaucoma. His research interests 
include the cellular and molecular mecha-
nisms of glaucomatous optic nerve damage, 
with the ultimate goal of identifying novel 
pathways for therapeutic intervention.
Amit Patel, MD 10, recently moved to 
North Carolina to take a position as assistant 
professor of medicine in the Division of 
Gastroenterology at Duke University School 
of Medicine.
Daniel Seitz, MD 13, graduated from 
the Indiana University School of Medicine 
Emergency Medicine Residency Program and 
has started a fellowship in clinical informatics 
at the Regenstrief Institute in Indianapolis.
While earning an MD/PhD from the School of Medicine, Leonid Shmuylovich co-founded Virtual Nerd LLC, an 
online tutoring company. As a passionate, part-time tutor 
eager to reach even more students, he began recording video 
explanations of common trouble topics and sharing them online. 
He then partnered with industrial designer Josh Salcman to 
further enhance the platform. Virtual Nerd was developed as a 
supplemental learning resource, with a focus on middle school 
and high school mathematics. Eventually, the pair sold the business to Pearson,  
the world’s leading education company, and helped develop Pearson’s award-
winning Mobile Math App. 
Shmuylovich, MD/PhD ’15, is now a second-year dermatology resident at Barnes-
Jewish Hospital. He also completed an internship in pediatrics at St. Louis Children’s 
Hospital, where he received the James P. Keating Outstanding Resident Award.
Shmuylovich and his wife, Ilana Rosman, MD ’08, assistant professor of 
dermatology and pathology, live in St. Louis with their two children. 
Alum co-founds online tutoring company
He lives in Indianapolis with his wife, 
Dianne, and 13-year-old son, Cameron. 
Their daughter, Amy, lives in St. Louis with 
her husband, Richard.
Michael Finley, PhD 98, started a new  
position as principal scientist in research and 
development at Janssen Pharmaceutical 
Companies of Johnson & Johnson in Spring 
House, Pa. 
David A. Dorr, LA 94, MD 99, was promoted 
to professor at Oregon Health & Science 
University, where he studies how to use data, 
information and knowledge to improve  
systems for vulnerable populations. He is 
married to Gabrielle Meyers, an oncologist. 
The couple has two daughters, ages 5 and 8.
Katherine Nowak, PT 99, EMBA 07, 
became vice president for care management 
informatics and business support for Mercy, 
based in Chesterfield, Mo., in August 2016. 
She assumed the role of Missouri regent 
for the American College of Healthcare 
Executives in March 2017.
2000S
Greg Janicki, PT 02, works as a physical 
therapist in Geneseo, Ill. He invented and is 
patenting and manufacturing the TriForce, a 
functional fitness and rehabilitation  
tool intended to help people achieve  
their movement goals.
OT honorees
The Program in Occupational Therapy is celebrating its 100-
year anniversary in October 2018. 
As part of the Centennial Gala, the 
program is recognizing outstanding 
alumni for individual achievements 
in or contributions to the field of 
occupational therapy in research, 
education, leadership, professional 
development or community 
participation. This is the first time 
the program has offered the award. 
Nominations for the Distinguished 
OT Program Alumni Award are being 
accepted July 1, 2017-Jan. 31, 2018,  
at ot.wustl.edu/otalumniaward.
Leanne Lin, MD 15, GM 13, a radi-
ology resident at the University of 
Kentucky in Lexington, competes 
in powerlifting.
Her current stats: 
SQUAT — 215 pounds
BENCH — 140 pounds
DEADLIFT — 270 pounds
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1940S 
Joseph Hunter Allen Jr., MD 48; Sept. ‘16
Aaron Birenbaum, MD 48; Nov. ‘16
Charles Glendenning Fullenwider, MD 
43; Oct. ‘16
Wilbert “Bill” Edgar Hieb, MD 44; March ‘16
Richard A. Preston, MD 42; Sept. ‘16
Clarence G. Schulz, MD 45; Nov. ‘16
Ruth E. Werner, OT 49; Jan. ‘17
1950S
Melvin H. Becker, LA 44, MD 50; Dec. ‘16
Richard Vernon Bradley, MD 52; Jan. ‘17
John Whitfield Drake II, MD 56; Nov. ‘16
Robert Echols, MD 50; Aug. ‘16
M. Ann Hunt, LA 47, MD 51; Oct. ‘16
Kathryn Mary Defler Lavrich, MD 51; 
Nov. ‘16
Ruth Lynch, NU 55; Nov. ’16
Joseph Kent McKinney, MD 58; Nov. ‘16
Robert Calvin Newell, MD 57; Aug. ‘16
Lloyd Hamilton Ramsey, MD 50; Oct. ‘16
Irwin “Izzy” Schultz, HS 56; Nov. ‘16
L.D. (Lari Daniel) Slane, DE 50; Jan. ‘17
Ethelee R. Smith, MD 56; Sept. ‘16
Stanley B. Smith, MD 56; Nov. ‘16
Herbert Sunshine, LA 50, MD 54, HS; Dec. ‘16
Gordon Clay Thompson, DE 52; Oct. ‘16
John C. Whitsell, MD 54; Oct. ‘16
Robert D. Winship, MD 53; Sept. ‘16
1960S
Sheftel Japhe “Shep” Cohen, MD 63; Oct. ‘16
Joann Miriam Gellman, NU 63; Nov. ‘16
John Hered, MD 67; Oct. ‘16
Michael J. Perley, MD 61; Sept. ‘16
Collyn Franzenburg Schmidt, GN 61; Oct. ‘16
1970S
Aaron M. Bernstein, LA 48, HS 73; Nov. ‘16
Chauncey C. Maher III, MD 72; Dec. ‘16
Janet Williamson, OT 71; Oct. ‘16
obituaries
Transplant pioneer dies at 78 
Helped establish kidney transplantation program at Barnes-Jewish Hospital
Charles B. Anderson, MD, a former professor and director of the Division of General Surgery, died of congestive heart failure Monday, Nov. 7, 2016, at his home in St. Louis. He was 78.
Anderson’s research and surgical expertise advanced the 
understanding of kidney transplantation and helped to establish the 
kidney transplantation program at Barnes-Jewish Hospital, where he 
served as general surgeon-in-chief.
He is widely respected for his work to combat organ rejection in 
kidney transplant patients. He proposed pre-surgical blood 
transfusions from organ donors, which provided recipients with protective antibodies and 
immunosuppression. The scientific community considered the concept controversial in the 
1970s when introduced by Anderson and his associate William T. Newton, MD, a former 
professor of surgery. However, it since has been accepted internationally.
He and Newton also established the pediatric kidney transplant program at St. Louis 
Children’s Hospital.
With colleague Gregorio A. Sicard, MD, a professor emeritus of surgery, Anderson 
developed vascular surgery into a specialty. Anderson was among the first U.S. surgeons to 
be certified in vascular surgery by the American Board of Surgery.
Anderson earned a bachelor’s degree from Johns Hopkins University in 1958 and medical 
degree from Yale University in 1962. He also completed an internship and residency in surgery 
at then-Barnes Hospital. Anderson served as a U.S. Navy medical officer from 1963 to 1965.
He was named full professor in 1979 and became director of the general surgery division in 1984.
Anderson married Marilynn Virginia Wolf in 1967. She preceded him in death. Survivors 
include his children, Kristin A. Redington (Jim), Cheryl A. Colonnello (Jamie) and Beth A. 
Stiska (Matt); and eight grandchildren. 
Matthew R. Barton, 
MD, a physician-scien-
tist in his seventh and 
final year of residency 
in otolaryngology at 
Barnes-Jewish Hospital 
and Washington 
University School of 
Medicine, died unexpectedly Monday, Jan. 
23, 2017, at his home in Webster Groves, 
Mo., of an undiagnosed medical condition. 
He was 35.
While in medical school, a research rota-
tion at the National Institutes of Health (NIH) 
in Bethesda, Md., introduced him to aca-
demic medicine and clinical investigation. 
The experience made him want to become a 
physician-scientist aimed at developing bet-
ter treatments for otolaryngology patients.
Barton is survived by his wife, Allison 
Barton; their children, Noah and Brooklyn; 
his parents, Michael and Deborah Barton; 
and his sister, Katie Barton.
 
Brian T. Collins, MD, 
an associate professor 
of pathology and 
immunology, died 
Friday, Dec. 23, 2016, 
in his sleep at his 
home in Creve Coeur, 
Mo. He was 52.
Chief of the cytopathology section at 
the school, his work focused on studying 
and diagnosing diseases on the cellular 
level, with a particular emphasis on using 
fine needles to rapidly obtain samples for 
molecular and other diagnostic tests.
Collins is survived by his wife, Virginia 
“Gini” Collins; children, Virginia A. “Gini,” 
Laura, John, Dianne and Maria Collins; 
parents, Steven and Virginia Collins; and 
brother, Scott Collins. 
.
 
Charles B. Anderson, MD
For full obituaries, visit: 
wumcnews.org/obits
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Science 
as art I
n this scanning electron microscope image, white blood cells (yellow-green) 
fail to control the bacteria (pink) causing a urinary tract infection in a 
mouse bladder (blue). The alluring image is a winner in the annual BioArt 
competition sponsored by the Federation of American Societies for 
Experimental Biology. The image was submitted by Scott Hultgren, PhD,  
the Helen L. Stoever Professor of Molecular Microbiology; Valerie O’Brien,  
a graduate student in Hultgren’s lab; James Fitzpatrick, PhD, director of  
the Center for Cellular Imaging; and Matthew Joens, a staff scientist in the 
Department of Neuroscience.
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Linked together
As part of an integrated campus plan, a new elevated walkway 
connects four employee garages to medical school buildings 
and hospitals, eliminating the need to cross busy traffic 
intersections. For added safety and comfort, the walkway 
requires badge-swipe access and contains emergency phones, 
benches, restrooms and a coffee shop. See story on page 7.
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